Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2003
10/30/2003US20030204083 Substituted 2-amino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203904 Antitumor agents for treating cancer
10/30/2003US20030203901 Methods of modulating tyrosine protein kinase function with indolinone compounds
10/30/2003US20030203890 Administering a neurotrophic compound 2-pyrrolidinecarboxylate derivatives after prostate surgery as well as erectile dysfunction
10/30/2003DE20312772U1 New solid, crystalline forms of ondansetron, useful e.g. for treating emesis, migraine or schizophrenia, having specific endothermal melting peak, base content or water content
10/30/2003CA2484017A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/29/2003EP1357121A1 Azaring-ether deritatives and their use as nicotinic ach receptor modulators
10/29/2003EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1356815A1 Analgesic and antiinflammatory drugs
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355903A1 Pyrazole derivatives against tgf overexpression
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355881A2 An improved process for preparing pure ondansetron hydrochloride dihydrate
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1153920B1 Quinoline derivatives and quinazoline derivatives
10/29/2003EP1149092B1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1125653C Pharmaceutical formulations containing voriconazole
10/28/2003US6639076 Such as 2-(2-amino-2-methylpropanoylamino)-n-(1-(2-oxo-1-phenyl-2-pyrrolidinylethyl -4-yl)-4-phenylbutanamide
10/28/2003US6638965 Antitumor agents
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638960 Use as microbicides, especially fungicides, in crop protection
10/28/2003US6638954 Δ2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
10/28/2003US6638953 Indole derivatives as 5-HT receptor antagonist
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638937 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
10/28/2003CA2104268C Preparation of imidazoles
10/23/2003WO2003087092A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
10/23/2003WO2003087091A1 Novel crystal of quinoxalinedione derivative anhydride
10/23/2003WO2003087088A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087086A2 Substituted indoles
10/23/2003WO2003087085A1 Heterocyclic amide derivatives as cytokine inhibitors
10/23/2003WO2003087064A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
10/23/2003WO2003087063A1 Imidazolidine compounds as chemokine receptor modulators
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087026A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003WO2003086403A1 Inhibitors of akt activity
10/23/2003WO2003086398A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003086385A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086318A2 Improved prodrugs of cc-1065 analogs
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086287A2 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003WO2003086271A2 Azole derivatives as antifungal agents
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003US20030199700 Preparation method of 2,2'-bi-1H-imidazole using glyoxal and an ammonium salt
10/23/2003US20030199691 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003US20030199689 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199565 Gastrin and cholecystokinin receptor ligands(II)
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199553 Antidiabetic agents
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199533 Administering amino, carboxy, alkyl derivatives of barbituric acid to treat diseases of the central nervous system related to the metabotropic glutamate receptor system
10/23/2003US20030199532 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists
10/23/2003US20030199530 New compounds derived from quinazoline
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199522 Such as (2S)-(-)-2-(2-aminoethoxy)-3-(1-phenyl-1H-imidazol-4-yl)propanoic acid for treating thrombosis, atherosclerosis, adhesions, scarring, cancer, fibrosis, inflammation, and conditions which benefit from maintaining brandykinin levels
10/23/2003US20030199519 Prodrugs of CC-1065 analogs
10/23/2003US20030199513 Cinnoline derivatives and use as medicine
10/23/2003US20030199511 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199473 For therapy of retrovirus infection
10/23/2003CA2485679A1 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003CA2482937A1 A novel crystal of anhydride of a quinoxalinedione derivative
10/23/2003CA2482544A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2480759A1 Improved prodrugs of cc-1065 analogs
10/22/2003EP1354882A1 Dipeptidyl peptidase iv inhibitor
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1125065C Benzo[g] quinoline derivatives
10/21/2003US6635771 N-benzhydryl indole compounds
10/21/2003US6635668 Imidazoline receptor binding compounds
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635639 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 ... 626